Vitrilife Technology
VitriLife is the 1st commercially scalable vitrification platform enabling industrial scale stabilization of biologicals
Technology Highlights:
-
Scalable and reproducible alternative to lyophilization resulting in superior stabilization.
-
Immobilizes biological materials in a foamed sugar glass matrix.
-
Arrests rotational and translational motion of molecules.
-
Achieves significant increases to product shelf life and improves activity yields.
-
Maintains higher titer after drying and subsequent storage.
-
Reduces storage, packaging, and shipping costs due to potential for ease of the cold chain burden.
-
Enables micronization (milling foam to powder) without product damage.
-
Enables formulation of combination/multi-component products.
-
Instantaneous reconstitution at site of delivery.
-
The cornerstone of the VitriLife platform is our patented state-of-the-art drying by boiling process known as preservation by vaporization (PBV).
Expertise formulating a range of biological products at elevated ambient temperatures:
-
Vaccines
-
Monoclonal Antibodies
-
Hormones
-
Growth Factors
-
Therapeutic Proteins
-
Biosimilars
-
Live Biotherapeutic Products (LBPs)
-
Agricultural Biologicals
-
Enzymes
-
Microbiome-based products